<?xml version="1.0" encoding="UTF-8"?>
<p>In addition to performing its own evaluations of 11 existing HIV incidence assays, since 2012 CEPHIA has distributed over 50 purposely designed specimen panels to 19 different research and development groups. Unified data from extensively characterized, highly valuable specimens has allowed this resource to support biomarker discovery, assay optimization, and development of new strategies for estimating duration of HIV infection by interpreting diagnostic histories, as shown in 
 <xref rid="T1" ref-type="table">Table 1</xref>.
</p>
